Works matching IS 00912700 AND DT 2024 AND VI 64 AND IP 11
Results: 13
Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti‐α‐Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1432, doi. 10.1002/jcph.6103
- By:
- Publication type:
- Article
Population Pharmacokinetics and Loading Dose Optimization of Intravenous Valproic Acid in Hospitalized Thai Patients.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1343, doi. 10.1002/jcph.6102
- By:
- Publication type:
- Article
Clinical Characteristics of Moxifloxacin‐Related Arrhythmias and Development of a Predictive Nomogram: A Case Control Study.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1351, doi. 10.1002/jcph.6101
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1419, doi. 10.1002/jcph.2492
- By:
- Publication type:
- Article
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1443, doi. 10.1002/jcph.2496
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of the New Aldose Reductase Inhibitor Govorestat (AT‐007) After a Single and Multiple Doses in Participants in a Phase 1/2 Study.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1397, doi. 10.1002/jcph.2495
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Dolutegravir in Treatment‐Experienced Adults Living with HIV‐1.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1407, doi. 10.1002/jcph.2494
- By:
- Publication type:
- Article
Pharmacokinetics of Human Plasma‐Derived Antithrombin in Pediatric Patients Supported on Extracorporeal Membrane Oxygenation.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1382, doi. 10.1002/jcph.2493
- By:
- Publication type:
- Article
A Model‐Informed Drug Development Approach Supporting the Approval of an Unstudied Valbenazine Dose for Patients With Tardive Dyskinesia.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1456, doi. 10.1002/jcph.2498
- By:
- Publication type:
- Article
Comparison of Anti‐Hepatitis A Antibody Pharmacokinetics in Healthy Australian Subjects Receiving Standard or Weight‐Based Dosing of Polyvalent Immunoglobulin.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1391, doi. 10.1002/jcph.2491
- By:
- Publication type:
- Article
Cerebrospinal Fluid Pharmacokinetics of Nicardipine Following Intrathecal Administration in Subarachnoid Hemorrhage Patients.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1373, doi. 10.1002/jcph.2488
- By:
- Publication type:
- Article
Drug‐Drug Interaction between Oral Zamicastat and Continuous Epoprostenol Infusion at Steady‐State Conditions in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1361, doi. 10.1002/jcph.2486
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1337, doi. 10.1002/jcph.2085
- Publication type:
- Article